Serum HCV RNA levels and HCV genotype do not affect insulin resistance in nondiabetic patients with chronic hepatitis C: a multicentre study
- 6 October 2009
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 30 (9) , 947-954
Abstract
Summary: Background Chronic hepatitis C (CHC) induces insulin resistance (IR) and subsequently diabetes.Aim To examine viral, metabolic and histological predictors of IR in 275 CHC patients to test the hypothesis that IR differs among HCV genotypes and that viral replication directly affects IR.Methods We studied 275 nondiabetic treatment‐naïve CHC patients. Histological lesions were evaluated according to Ishak. IR was assessed using homeostasis model assessment for insulin resistance (HOMA‐IR).Results HOMA > 3.0 was found in 37% of patients, independently associated with higher BMI and GGT. In genotype non‐3 patients, HOMA > 3.0 was associated with higher BMI and GGT values, while no significant association was noted in genotype 3 patients. In non‐obese patients with minimal fibrosis, HOMA > 3.0 was found in 20% of cases without significant differences among genotypes. No association between HOMA > 3.0 and HCV‐RNA levels was found. Severe fibrosis (stage 5–6) related to older age (OR:1.048), HOMA‐IR (OR:1.177), necroinflammation (OR: 2.990) and higher ALT (OR: 1.009) and GGT (OR:1.006).Conclusions IR develops at early stages of CHC without significant differences among genotypes. It is more frequent in obese patients with steatosis and contributes to fibrosis progression. However, IR does not seem to be associated with viraemia and therefore its exact pathogenetic mechanism in CHC remains elusive.Keywords
This publication has 28 references indexed in Scilit:
- Insulin resistance and metabolic syndrome in chronic liver diseases: Old entities with new implicationsScandinavian Journal of Gastroenterology, 2009
- Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokinesHepatology, 2007
- Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor‐α in chronic hepatitis C patientsAlimentary Pharmacology & Therapeutics, 2006
- Insulin resistance and HCV: Will new knowledge modify clinical management?Journal of Hepatology, 2006
- Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C†Hepatology, 2005
- Peroxisome proliferator‐activated receptor‐α and ‐γ mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infectionAlimentary Pharmacology & Therapeutics, 2005
- Sources of variability in histological scoring of chronic viral hepatitis†Hepatology, 2005
- Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progressionGastroenterology, 2003
- Impaired Irs–1/Pi3–Kinase Signaling in Patients With Hcv: A Mechanism for Increased Prevalence of Type 2 DiabetesHepatology, 2003
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995